Latest Insider Transactions at Allscripts Healthcare Solutions, Inc. (MDRX)
This section provides a real-time view of insider transactions for Allscripts Healthcare Solutions, Inc. (MDRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 28
2021
|
Paul Black Director |
SELL
Payment of exercise price or tax liability
|
Direct |
66,554
-1.89%
|
$998,310
$15.43 P/Share
|
Feb 28
2021
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,910
-3.83%
|
$313,650
$15.43 P/Share
|
Feb 28
2021
|
Richard J. Poulton CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
49,589
-6.93%
|
$743,835
$15.43 P/Share
|
Feb 27
2021
|
Paul Black Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,560
-0.81%
|
$218,400
$15.43 P/Share
|
Feb 27
2021
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,740
-2.36%
|
$101,100
$15.43 P/Share
|
Feb 27
2021
|
Richard J. Poulton CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
25,012
-3.38%
|
$375,180
$15.43 P/Share
|
Feb 26
2021
|
Paul Black Director |
SELL
Payment of exercise price or tax liability
|
Direct |
20,019
-1.1%
|
$300,285
$15.43 P/Share
|
Feb 26
2021
|
Paul Black Director |
BUY
Grant, award, or other acquisition
|
Direct |
178,572
+8.97%
|
-
|
Feb 26
2021
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,632
-2.94%
|
$129,480
$15.43 P/Share
|
Feb 26
2021
|
Lisa Khorey Chief Client Delivery Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,143
+16.28%
|
-
|
Feb 26
2021
|
Richard J. Poulton CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
32,163
-2.1%
|
$482,445
$15.43 P/Share
|
Feb 26
2021
|
Richard J. Poulton CEO |
BUY
Grant, award, or other acquisition
|
Direct |
142,858
+15.59%
|
-
|
Feb 26
2021
|
Tejal Vakharia SVP General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
28,572
+10.78%
|
-
|
Feb 18
2021
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.96%
|
$240,000
$16.75 P/Share
|
Dec 14
2020
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
60,000
-3.53%
|
$840,000
$14.03 P/Share
|
Nov 18
2020
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.63%
|
$180,000
$12.75 P/Share
|
Nov 14
2020
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,263
-1.57%
|
$51,156
$12.25 P/Share
|
Oct 14
2020
|
Lisa Khorey Chief Client Delivery Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.25%
|
$165,000
$11.04 P/Share
|
Oct 14
2020
|
Paul Black Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.73%
|
$330,000
$11.04 P/Share
|